olmesartan has been researched along with choline in 1 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (choline) | Trials (choline) | Recent Studies (post-2010) (choline) |
---|---|---|---|---|---|
841 | 185 | 554 | 19,628 | 608 | 4,345 |
Protein | Taxonomy | olmesartan (IC50) | choline (IC50) |
---|---|---|---|
Sodium- and chloride-dependent creatine transporter 1 | Rattus norvegicus (Norway rat) | 1.6 | |
High affinity choline transporter 1 | Mus musculus (house mouse) | 1.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akisawa, N; Hirose, A; Iwasaki, S; Masuda, K; Nozaki, Y; Oben, JA; Onishi, S; Ono, M; Saibara, T; Takahashi, M; Yoshioka, A | 1 |
1 other study(ies) available for olmesartan and choline
Article | Year |
---|---|
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animal Feed; Animals; Choline; Connective Tissue Growth Factor; Fatty Liver; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Liver Cirrhosis; Male; Methionine; Oxidative Stress; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2007 |